FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096986475> ?p ?o ?g. }

• W3096986475 abstract "Abstract Detecting persistent minimal residual disease (MRD) allows the identification of patients with an increased risk of relapse and death. In this study, we have evaluated MRD 3 months after transplantation in 106 myeloma patients using a commercial next-generation sequencing (NGS) strategy (LymphoTrack®), and compared the results with next-generation flow (NGF, EuroFlow). The use of different marrow pulls and the need of concentrating samples for NGS biased the applicability for MRD evaluation and favored NGF. Despite that, correlation between NGS and NGF was high ( R 2 = 0.905). The 3-year progression-free survival (PFS) rates by NGS and NGF were longer for undetectable vs. positive patients (NGS: 88.7% vs. 56.6%; NGF: 91.4% vs. 50%; p < 0.001 for both comparisons), which resulted in a 3-year overall survival (OS) advantage (NGS: 96.2% vs. 77.3%; NGF: 96.6% vs. 74.9%, p < 0.01 for both comparisons). In the Cox regression model, NGS and NGF negativity had similar results but favoring the latter in PFS (HR: 0.20, 95% CI: 0.09–0.45, p < 0.001) and OS (HR: 0.21, 95% CI: 0.06–0.75, p = 0.02). All these results reinforce the role of MRD detection by different strategies in patient prognosis and highlight the use of MRD as an endpoint for multiple myeloma treatment." @default.
• W3096986475 created "2020-11-09" @default.
• W3096986475 creator A5001843419 @default.
• W3096986475 creator A5014210044 @default.
• W3096986475 creator A5015898454 @default.
• W3096986475 creator A5020702876 @default.
• W3096986475 creator A5020989412 @default.
• W3096986475 creator A5021328479 @default.
• W3096986475 creator A5029159537 @default.
• W3096986475 creator A5031837957 @default.
• W3096986475 creator A5032091177 @default.
• W3096986475 creator A5034182883 @default.
• W3096986475 creator A5035567665 @default.
• W3096986475 creator A5045863854 @default.
• W3096986475 creator A5046656441 @default.
• W3096986475 creator A5047672322 @default.
• W3096986475 creator A5047866471 @default.
• W3096986475 creator A5053642352 @default.
• W3096986475 creator A5054952877 @default.
• W3096986475 creator A5057189669 @default.
• W3096986475 creator A5059482051 @default.
• W3096986475 creator A5064147442 @default.
• W3096986475 creator A5072069069 @default.
• W3096986475 creator A5075422618 @default.
• W3096986475 creator A5076639094 @default.
• W3096986475 creator A5077373236 @default.
• W3096986475 creator A5088409474 @default.
• W3096986475 date "2020-10-30" @default.
• W3096986475 modified "2023-10-18" @default.
• W3096986475 title "Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma" @default.
• W3096986475 cites W1957050270 @default.
• W3096986475 cites W1975542133 @default.
• W3096986475 cites W1985012922 @default.
• W3096986475 cites W1990835696 @default.
• W3096986475 cites W2018476550 @default.
• W3096986475 cites W2020094108 @default.
• W3096986475 cites W2037050131 @default.
• W3096986475 cites W2044436186 @default.
• W3096986475 cites W2086061986 @default.
• W3096986475 cites W2086595383 @default.
• W3096986475 cites W2096999034 @default.
• W3096986475 cites W2128192762 @default.
• W3096986475 cites W2134001103 @default.
• W3096986475 cites W2134902298 @default.
• W3096986475 cites W2144728882 @default.
• W3096986475 cites W2165574508 @default.
• W3096986475 cites W2486629951 @default.
• W3096986475 cites W2514823597 @default.
• W3096986475 cites W2518827451 @default.
• W3096986475 cites W2524904048 @default.
• W3096986475 cites W2579739608 @default.
• W3096986475 cites W2601172279 @default.
• W3096986475 cites W2613844594 @default.
• W3096986475 cites W2772566228 @default.
• W3096986475 cites W2780353907 @default.
• W3096986475 cites W2893245372 @default.
• W3096986475 cites W2900691306 @default.
• W3096986475 cites W2928272073 @default.
• W3096986475 cites W2972305086 @default.
• W3096986475 cites W2990816134 @default.
• W3096986475 cites W3045223998 @default.
• W3096986475 doi "https://doi.org/10.1038/s41408-020-00377-0" @default.
• W3096986475 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7603393" @default.
• W3096986475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33127891" @default.
• W3096986475 hasPublicationYear "2020" @default.
• W3096986475 type Work @default.
• W3096986475 sameAs 3096986475 @default.
• W3096986475 citedByCount "55" @default.
• W3096986475 countsByYear W30969864752021 @default.
• W3096986475 countsByYear W30969864752022 @default.
• W3096986475 countsByYear W30969864752023 @default.
• W3096986475 crossrefType "journal-article" @default.
• W3096986475 hasAuthorship W3096986475A5001843419 @default.
• W3096986475 hasAuthorship W3096986475A5014210044 @default.
• W3096986475 hasAuthorship W3096986475A5015898454 @default.
• W3096986475 hasAuthorship W3096986475A5020702876 @default.
• W3096986475 hasAuthorship W3096986475A5020989412 @default.
• W3096986475 hasAuthorship W3096986475A5021328479 @default.
• W3096986475 hasAuthorship W3096986475A5029159537 @default.
• W3096986475 hasAuthorship W3096986475A5031837957 @default.
• W3096986475 hasAuthorship W3096986475A5032091177 @default.
• W3096986475 hasAuthorship W3096986475A5034182883 @default.
• W3096986475 hasAuthorship W3096986475A5035567665 @default.
• W3096986475 hasAuthorship W3096986475A5045863854 @default.
• W3096986475 hasAuthorship W3096986475A5046656441 @default.
• W3096986475 hasAuthorship W3096986475A5047672322 @default.
• W3096986475 hasAuthorship W3096986475A5047866471 @default.
• W3096986475 hasAuthorship W3096986475A5053642352 @default.
• W3096986475 hasAuthorship W3096986475A5054952877 @default.
• W3096986475 hasAuthorship W3096986475A5057189669 @default.
• W3096986475 hasAuthorship W3096986475A5059482051 @default.
• W3096986475 hasAuthorship W3096986475A5064147442 @default.
• W3096986475 hasAuthorship W3096986475A5072069069 @default.
• W3096986475 hasAuthorship W3096986475A5075422618 @default.
• W3096986475 hasAuthorship W3096986475A5076639094 @default.
• W3096986475 hasAuthorship W3096986475A5077373236 @default.
• W3096986475 hasAuthorship W3096986475A5088409474 @default.
• W3096986475 hasBestOaLocation W30969864751 @default.
• W3096986475 hasConcept C126322002 @default.
• W3096986475 hasConcept C143998085 @default.

• next